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Background: Cancer survivorship rates have increased in developed countries largely due to population ageing
and improvements in cancer care. Survivorship is a neglected phase of cancer treatment and is often associated
with adverse physical and psychological effects. There is a need for broadly accessible, non-pharmacological
measures that may prolong disease-free survival, reduce or alleviate co-morbidities and enhance quality of life.
The aim of the Steps TowaRd Improving Diet and Exercise (STRIDE) study is to evaluate the effectiveness of an
online-delivered physical activity intervention for increasing walking in cancer survivors living in metropolitan
and rural areas of South Australia.
Methods/Design: This is a quasi-randomised controlled trial. The intervention period is 12-weeks with 3-month
follow-up. The trial will be conducted at a university setting and community health services in South Australia.
Participants will be insufficiently active and aged 18 years or older. Participants will be randomly assigned to
either the intervention or control group. All participants will receive a pedometer but only the intervention
group will have access to the STRIDE website where they will report steps, affect and ratings of perceived
exertion (RPE) during exercise daily. Researchers will use these variables to individualise weekly step goals to
increase walking.
The primary outcome measure is steps per day. The secondary outcomes are a) health measures (anthropometric and
physiological), b) dietary habits (consumption of core foods and non-core foods) and c) quality of life (QOL) including
physical, psychological and social wellbeing. Measures will be collected at baseline, post-intervention and 3-month
follow-up.
Discussion: This protocol describes the implementation of a trial using an online resource to assist cancer survivors to
become more physically active. It is an innovative tool that uses ratings of perceived exertion and daily affect to create
individualised step goals for cancer survivors. The research findings may be of relevance to public health policy
makers as an efficacious and inexpensive online-delivered intervention can have widespread application and may
improve physical and psychological outcomes among this vulnerable population. Findings may indicate directions
for the implementation of future physical activity interventions with this population.
Trial registration: Australian New Zealand Clinical Trials Registry: ACTRN12613000473763.
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The number of cancer survivors in Australia is increasing
due to population ageing, growing incidence of some can-
cers and improvements in early detection and treatment
[1]. However, cancer survivorship care is a neglected phase
of the cancer care trajectory. The medical system tends to
focus primarily on curing the cancer rather than managing
the after-effects of treatment. Cancer and its treatments
are often associated with adverse physical and psycho-
logical effects that can persist for months or years after
treatment. Such after-effects can include fatigue, func-
tional impairment, weight gain, sleeping difficulties and
reduction in quality of life [2-7].
Increasing physical activity provides a non-pharmacologic
strategy for the prevention and/or alleviation of many of
these effects. Evidence has consistently indicated that
physical activity has a positive impact on physiological
outcomes (e.g. cardiovascular fitness, physical functioning,
immune function, muscle strength, body composition,
nausea and fatigue) and psychological wellbeing (e.g. mood,
self-esteem, anxiety and depression) following a cancer
diagnosis [8-13].
Despite these health benefits, many cancer survivors
are not sufficiently physically active [14]. Cancer survi-
vors living in rural and remote areas are at even higher
risk of being physically inactive and experiencing nega-
tive effects after treatment than their urban counterparts
[15,16]. This may be due to unique features of the rural
environment including geographic diversity, social isola-
tion, limited access to treatment services and facilities
and the burden of travel distances [17]. Thus, there is a
need for tailored, broadly accessible health promotion
interventions to improve outcomes for survivors living
in both metropolitan and rural areas.
The purpose of this paper is to describe the protocol
of the STRIDE 12- week intervention, which has been
specifically designed to test the effectiveness of an online
resource for increasing regular walking and improving
health and quality of life outcomes among cancer survi-
vors living in metropolitan and rural areas. The trial also
aims to identify whether there are region specific (metro-
politan versus rural) predictors of successful engagement
with the intervention. To our knowledge, it will be the
first to use ratings of perceived exertion (RPE) and daily
affect to deliver individualised, incremental step goals for
participants relative to their baseline values.
Theoretical framework
STRIDE is designed upon social cognitive theory which
posits that physical activity interventions are most effect-
ive when they include intrapersonal mediators (including
goal setting, self-monitoring and self-efficacy), social
mediators (family and peer support), and environmental
mediators (access to facilities and opportunities) [18-20].Concepts from Locke and Latham’s [21] goal setting the-
ory will also be integrated by encouraging 1) goal accept-
ance (participants will be provided with a workshop of the
importance of active lifestyles thus placing importance on
the achievement of their step goals); 2) goal specificity
(step goals will be tailored to the individual taking into
consideration their affect and level of physical capability);
3) providing difficult goals (step goals will be set high
enough to encourage high performance but low enough to
be attainable); and 4) feedback (a graph on the STRIDE




The STRIDE study is a quasi-randomised controlled
intervention trial. Participants will be allocated to either
the intervention group or the wait-list control group.
Approximately 80 participants will be recruited and ran-
domised by the research investigator(s). Table 1 shows
the inclusion and exclusion criteria.
Study design and recruitment procedures
Recruitment and screening
The study flow is presented in Figure 1. Participants will
be recruited via cancer support groups, newspaper adver-
tisements, hospitals, flyers, government departments and
allied health personnel contacts. Potential participants will
firstly be screened by telephone to determine eligibility,
and if eligible will be provided with further study informa-
tion, a consent form and pre-exercise screening form,
and asked to obtain medical clearance from their treat-
ing doctor using a standardised medical clearance form.
Pre-exercise screening will be conducted using Stage 1
of the Sports Medicine Australia Pre-Exercise Screening
System [23]. The first stage of the screening system is
designed to screen out those people who are at a high
risk for exercise-related complications due to underlying
cardiovascular, cerebrovascular, respiratory or metabolic
diseases and also pre-existing injuries. Upon completion
and receipt of required consent and clearance forms by
the research team, participants will be randomised into
treatment conditions and contacted to make arrange-
ments for study participation.
Randomisation and blinding
Participants will be randomly allocated to one of the two
trial arms (intervention or wait-list control). A block de-
sign with allocation weight of 3:3 will be used to generate
treatment allocation. It is not possible for three key re-
searchers (LF, DZ, RS) to be blinded to participants’
group allocation as they will be performing the informa-
tion sessions relevant to each group. It is not possible to
blind participants to group allocation due to the nature
Table 1 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
• Age over 18 years, no age limit higher • Patient with metastasis,
• Have had cancer treated with curative intent (excluding skin cancer) • Pregnant or intending to become pregnant during study period,
• Not undergoing active treatment (including chemotherapy and
radiotherapy but will be included if taking long-term follow-up
medications or therapies such as hormone therapy)
• Physical or psychological condition (i.e. cognitive decline) that
may impede their participant in the study
• Permanent resident of South Australia,
• Insufficiently active (engaging in less than 20 sessions of physical
activity, one session lasting 30 minutes) over the past month determined
by The Active Australia Survey [22]
• Regular access to the internet (whether it be personal access or
through a library or community centre)
• Sufficient English language skills and cognitive ability to complete
questionnaires,
• Satisfy stage one of the pre-exercise screening guidelines for
commencing exercise determined by the Sports Medicine
Australia Pre-Exercise Screening System [23]
• Approval by treating doctor to be part of the study,
• Provide written informed consent
Assess eligibility
Exclude
Do not meet inclusion criteria
Decline to participate
Other reasons
Health measures, questionnaires, sealed 
pedometer
Health measures, questionnaires, sealed 
pedometer
Allocated to intervention
Receive 12-week online Stride program
Health measures, questionnaires, sealed 
pedometer
Health measures, questionnaires, sealed 
pedometer
Allocated to wait-list control
Receive 12-week Stride program
Health measures, questionnaires, sealed 
pedometer




















Figure 1 Flow of participants in study.
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physical and questionnaire measurements will be blinded
to the participants’ group allocation.
Ethical approval
This study has received ethical approval from the
University of South Australia Human Research Ethics
Committee prior to study commencement and is regis-
tered with the Australian New Zealand Clinical Trials
Registry (Trial Registration: ACTRN12613000473763).
Protocol
All participants will attend two baseline workshops, one
week apart. Each session will last approximately 90 minutes.
At the first workshop, health measures will be taken (blood
pressure, weight, height, waist and hip circumference) and
fitness will be assessed using the 6-minute walk test. Partici-
pants will complete questionnaires about their physical
functioning, quality of life and diet habits. They will be pro-
vided with a sealed pedometer (New-Lifestyles NL-1000
pedometer, New Lifestyles Inc., Lees Summit, MO) to wear
for seven consecutive days (5 week days and 2 weekend
days) which they will return at session two. At session two
all participants will be provided with lifestyle informa-
tion and a pedometer for use in the intervention (Yamax
Digiwalker SW700). Those in the intervention group
will be instructed on using the STRIDE website includ-
ing how to log their steps and report their RPE and
affect each day. On the basis of this information, they
will be emailed weekly step goals which they will be
encouraged to achieve. Following the 12-weeks of the
intervention period, all measures will be repeated, and
again after 6-months (i.e. 3-months post-intervention).
At the conclusion of 6-months the control group will be
offered the STRIDE program.
Intervention – STRIDE website
The STRIDE intervention involves two key components,
the STRIDE website and weekly step goals which partici-
pants are encouraged to achieve daily. Participants use a
pedometer to monitor the number of steps taken each
day, and record their daily steps using the step log on
the STRIDE website. In addition to steps taken, partici-
pants will report their RPE and affect daily (described
below). The step log screen will include a graph of average
weekly steps which provides participants with feedback on
progress throughout the intervention. There will also be
an online forum through which participants can share ex-
periences and provide peer support. Social support has
been consistently reported as a predictor of maintained
behaviour change in lifestyle promotion [24-28]. A virtual
notice board will provide space for community service
providers such as community centres, health services and
walking groups to advertise events and activities, as wellas provide high quality evidence-based guidance on lifestyle
behaviours. This feature will be designed to reduce environ-
mental barriers by increasing access to safe, supervised and
socially focused opportunities for cancer survivors and fam-
ily members. The website will also include information on
healthy eating based on the Cancer Council Australia’s nu-
trition guidelines that in turn are based on recommenda-
tions in The Australian Guide to Healthy Eating [29].
Step goals
Personalised step targets will be created using individuals’
RPE and affect. RPE is determined using Borg’s (1998)
6–20 Ratings of Perceived Exertion (RPE) scale [30] that
numerically quantifies the effort, strain, discomfort and/
or fatigue experienced during physical activity to repre-
sent how difficult or easy the activity is perceived to be
[30]. RPE has been used to create target exercise inten-
sities in a range of populations including healthy adults
[31,32], cardiac patients [33] and patients with chronic
obstructive pulmonary disease [34-36]. Researchers have
suggested that RPE can be beneficial to elderly or patient
populations where direct methods using maximal exertion
are considered unsafe [37]. Research has indicated that
affective state (feeling good/bad) influences exercise be-
haviour and motivation [38]. Given that a population such
as cancer survivors may experience wide variability in
affective state, how the individual is feeling will be taken
into account when setting the individualised step goals.
Participants will rate their affective state (i.e. how they feel
[good or bad]) each day on a scale of +5 (‘Very good’)
to −5 (‘Very bad’) [39].
Researchers on the STRIDE research team will use
these inputs (daily steps, RPE during walking and daily
affect) to generate individually tailored target steps/day
for the following week that maintain exertion at between
RPE 11 (light) and 13 (somewhat hard) on the RPE scale,
the “bandwidth” within which people have the most
positive response to exercise [40-42]. Three-tiered step
goals will be provided to participants using the affect
scale – a goal for when the participant is feeling ‘bad’ (i.e.
minus on the affect scale), ‘neutral’ and ‘good’. This method
will be employed to ensure that the goals are perceived to
be challenging yet achievable, as recommended by Locke
and Latham [21], even with variability in affective state
from one day to the next. That is, the goals will take into
account how the individual feels and be higher when affect
is ‘good’ than ‘neutral’ and ‘bad’.
The step goals will be determined from steps, RPE and
affect reported in the previous week. If participants do
not meet the step goals set for the previous week on
most days, the goal for the following week will not
change from the previous week. The first week will serve
as baseline data on which to set the first goals, with 0%,
5% and 10% increments on average steps achieved set
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were set by LF and DZ and confirmed by JD and GP.
Outcome measures
Outcome measures will be assessed at three time points:
baseline, end-program (week 13) and at the 3-month
follow-up. The primary outcome is daily steps. Partici-
pants will wear a sealed pedometer (New-Lifestyles
NL-1000 pedometer, New Lifestyles Inc., Lees Summit,
MO) for seven consecutive days (5 week days and 2
weekend days), except for sleeping, showering, bathing,
swimming or engaging in contact sports. Minimum wear
time, as recorded by a log sheet, will be defined as 10 hours
per day for four of the seven days, one of which must be a
weekend day. The NL series pedometer has extensive em-
pirical backing in the literature for validity and reliability,
and displays the accuracy required to detect changes in
step counts that are typical of walking interventions [43].
Secondary outcomes include:
Anthropometry
The following anthropometric measures will be taken:
standing stretch stature using a portable stadiometer
(SECA, Hamburg, Germany); body weight (Tanita UM-108,
Tanita Corporation, China); and waist and hip girths
(Executive Thinline 2 m W606pm, Lufkin Tape, Apex,
NC). All physical measurements will be taken accord-
ing to the International Standards for Anthropometric
Assessment [44]. A minimum of two measures will be
taken at each site. A third measure will be taken if the
difference between the first and second measures is
greater than 0.5 cm for stature, waist and hip girths.
Physiological measures
Resting blood pressure will be measured after participants
have been seated for five minutes using automated sphyg-
momanometers (Dinamap Pro 100, GE Medical Systems
Information Technologies and Critkon Company, LLC,
United Kingdom). Measures will be repeated until there
are two readings within 5 mmHg for both systolic and dia-
stolic pressure, up to a maximum of four times.
Diet quality
A semi-quantitative Dietary Questionnaire for Epidemio-
logical Studies (DQES) developed by the Cancer Council
of Victoria [29] will be used to assess change in dietary
habits. The DQES asks about food intake over the previ-
ous 12 months. It contains 74 items with 10 frequency re-
sponse options ranging from “Never” to “3 or more times
per day”. The questionnaire also contains three photo-
graphs of scaled portions of four foods, questions on the
overall frequency of fruit and vegetable consumption and
questions on consumption of foods that do not fit easily
into the frequency format, such as breads.The 74 food items are grouped into four categories:
cereal foods, sweets and snacks; dairy products, meats and
fish; fruit; and vegetables. A separate set of questions
covers intake of alcoholic beverages. The DQES takes ap-
proximately 30–45 minutes to complete. The DQES has
been validated in mid-age Australian women [45] and a
community sample of young Australian adults [46].
Sweetened drink intake (soft-drink, sports drinks, en-
ergy drinks, fruit drinks and cordial) will be measured
using a separate three-item questionnaire as sweetened
drink intake is not measured in the Cancer Council
DQES. For each sweetened drink participants indicate
how often, on average, they consumed the drink in the
previous 12 months on a 10-point scale ranging from
never to three or more times per day, and how much they
usually consume on a 3-point scale comprised of one glass
(250 ml), one can (375 ml) or one bottle (600 ml).
Mediators of physical activity change
The Physical Activity Maintenance Assessment (PAMA)
will be used to measure participant motivation (10 items),
self-efficacy (5 items) and confidence in maintaining phys-
ical activity (3 items). Responses will be measured on a
5-point Likert Scale ranging from ‘very unlike me’ to
‘very much like me’. Evidence shows that the PAMA has
predictive validity with other accepted measures of phys-
ical activity (e.g. VO2 max and energy expenditure, as
measured by the 7-Day Physical Activity Recall) and other
health characteristics that are associated with regular
physical activity (e.g., lower body mass index and reduced
scores on the Beck Depression Inventory [47].
Functional status and quality of life
Functional status and quality of life will be measured
using the Australian adaptation of the Short Form (36)
Health Survey (SF-36) [48]. The SF-36 comprises 36 items
representing eight domains of health and quality of life:
vitality; physical functioning; bodily pain; general health
perceptions; physical role functioning, emotional role
functioning; social role functioning; and mental health.
By combining these eight domains, two further sub-
scales are derived: Physical Component Scale (PCS) and
Mental Component Scale (MCS). Where necessary, scales
are reverse-scored so that a higher score indicates better
health. The SF-36 has been used in other studies of
lifestyle interventions among cancer survivors and in
self-management interventions in chronic disease [49,50].
Consistent with reliability analysis of the American ver-
sion, all scales of the Australian version of the SF-36 dem-
onstrate high internal consistency, with Cronbach’s alpha
ranging from 0.81 (General Health) to 0.92 (Physical
Functioning and Bodily Pain). The median of item-scale
correlations within each scale ranged from 0.61 (Mental
Health) to 0.82 (Role-Physical) [47].
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A brief questionnaire will be used to assess demographic
characteristics including age, gender, marital status, eth-
nicity, level of education, cancer type, cancer stage at
diagnosis and treatment type(s).
Statistical considerations
Sample size calculation
A priori power calculations determined that a sample of
44 participants per group (n = 88) is needed to detect
moderate effect sizes (r = 0.30-0.50) with 80% power and
a significance level (alpha) of 0.05. Allowing for 20%
dropout, 55 participants are required per group. Allowing
for adjustment by baseline measure (r = 0.05) a total of 41
participants per group (n = 82) will be recruited.
Analytic plan
Data will be entered and analysed using the IBM SPSS
version 21 (SPSS, Inc, Chacago, IL) statistical software
package. The intent-to-treat principle will be applied
and the significance level will be set at 0.05. Baseline
comparisons of demographic outcomes will be performed
using independent samples t-tests. The primary outcome
(number of steps/day) will be reported as independent
samples t-tests comparing change scores in the two
randomisation groups. Change scores for the second-
ary outcomes (health measures, diet quality and quality of
life) will be calculated for each variable and compared be-
tween treatment and control groups using parametric or
non-parametric procedures as appropriate for the data
distributions.
Random effects mixed modelling will be used with time
(0, 12, and 24 weeks) and group allocation (Intervention,
Control) as the fixed factors. A time by group interaction
term will be used to formally test the aims of the study.
Time by region (rural versus metropolitan) repeated
measures ANOVA will be used to examine differences in
the primary and secondary outcomes between groups over
time. Sociodemographic factors and diet will be controlled
for in the analysis.
Discussion
Cancer survivors commonly experience negative effects
following cancer and its treatment(s), including fatigue,
functional impairment, weight gain and cancer recurrence
[2-6]. Engagement in regular physical activity may ameli-
orate or prevent such adverse effects and enhance quality
of life [8-13]. This research involves the development and
trial of an online resource to assist cancer survivors in
both metropolitan and rural areas to become more physic-
ally active and to adopt a healthier diet. Currently, there
are no existing step guidelines for cancer survivors. A
value of 10,000 steps per day for healthy adults is often re-
ported in the media as an appropriate goal. However, sucha universal goal may not be achievable for those who have
had cancer. The STRIDE study will contribute signifi-
cantly to the literature as it will use RPE and daily affect
to create individualised, incremental step goals relative to
the individual’s baseline values. Thus the intervention will
be tailored to the survivor’s current capacity for physical
activity. The online delivery of the program will allow wide
community reach and dissemination, which is particularly
important among cancer survivors in rural communities
who have reduced access to services and facilities com-
pared to their urban counterparts. Specifically, the results
from this study could form the basis of the development
of a specific exercise prescription for this population.
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